ADVANCED TISSUE SCIENCES INC
S-3, EX-23, 2000-09-25
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ADVANCED TISSUE SCIENCES INC, S-3, EX-5, 2000-09-25
Next: HEARTLAND TECHNOLOGY INC, DEF 14A, 2000-09-25



                                                                    EXHIBIT 23.1




               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITIORS

     We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Advanced Tissue
Sciences, Inc. for the registration of 3,494,365 shares of its common stock and
to the incorporation by reference therein of our report dated February 1, 2000,
with respect to the consolidated financial statements of Advanced Tissue
Sciences, Inc., and our report dated January 19, 2000, with respect to the
combined financial statements of the Dermagraft Joint Venture included in the
Annual Report (Form 10-K) of Advanced Tissue Sciences, Inc. for the year ended
December 31, 1999, filed with the Securities and Exchange Commission.


                                                          /s/ Ernst & Young LLP

                                                           ERNST & YOUNG LLP




San Diego, California
September 22, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission